EBERS at the ESOT 2021 congress in Milan

The ARK normothermic perfusion system from EBERS was showcased during the TERMIS-AM conference that took place on August 29th-1st September in Milan, Italy. The company was present with a stand in the commercial exhibition of the conference. In addition, the company also participated in the Machine Perfusion Lab, which included two hands-off demonstration sessions where delegates of the congress had the possibility of seeing the ARK Kidney device in normal operation with porcine kidneys. The company was represented by its CEO, Pedro Moreo, and CTO, Víctor Alastrué.

ESOT 1ESOT 2

Presentation of results at the Spanish Society for Transplantation meeting (SET 2021)

EBERS’ research collaborator, Dr. Álex Gutiérrez, presented the last results obtained with the ARK normothermic perfusion system for ex vivo kidney preservation at the annual meeting of the Spanish Society for Transplantation (SET 2021). The scientific meeting was expected to take place in Málaga, Spain on February 12 – 14, but due to the restrictions imposed by the COVID-19 pandemic it was celebrated virtually. Dr. Gutiérrez gave an oral presentation titled “Ex vivo normothermic perfusion reduces cold ischemic damage and delayed graft function in an experimental model of renal transplantation”, where he discussed the benefits obtained in post-transplant renal function derived from the use of EBERS’ ARK KIDNEY device during the preservation of the graft.

Portada

Oral presentation in the Clinical Sessions of the Clinical Hospital of Barcelona

EBERS was represented by its CEO, Pedro Moreo, in the Clinical Sessions of Transplant Coordination Unit of the Clinical Hospital of Barcelona, organized by DTI Foundation and celebrated virtually on January 27, 2021. Dr. Moreo was invited to give a talk in the session titled “Organ perfusion systems: a solution for the future”, where he introduced the ARK KIDNEY system for renal transplantation and gave his view on the changes that will take place in the field of organ transplantation thanks to the dissemination of ex vivo normothermic perfusion technology.

póster webinar 27-01-2021

Participation in The Transplantation Society 28thInternational Congress (TTS 2020)

EBERS’ CEO, Pedro Moreo, participated in the 28th International Congress of The Transplantation Society, which was celebrated virtually on September 13-16, 2020. Dr. Moreo was invited to participate in a session titled “New technologies applied to organ donation", chaired by Dr. Estephan Arredondo, where he discussed about the benefits of ex vivo normothermic perfusion to improve organ quality and assess the organ viability in the fields of renal and hepatic transplantation.

logo TTS 2020